Characteristics of Clinical Trial Participants with Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)

Background: Therapeutic trials are critical to improving outcomes for individuals diagnosed with Duchenne muscular dystrophy (DMD). Understanding predictors of clinical trial participation could maximize enrollment. Methods: Data from six sites (Colorado, Iowa, Piedmont region North Carolina, South...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathews, Katherine D., Conway, Kristin M., Gedlinske, Amber M., Johnson, Nicholas, Street, Natalie, Butterfield, Russell J., Hung, Man, Ciafaloni, Emma, Romitti, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534386/
https://www.ncbi.nlm.nih.gov/pubmed/34682100
http://dx.doi.org/10.3390/children8100835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534386/
https://www.ncbi.nlm.nih.gov/pubmed/34682100
http://dx.doi.org/10.3390/children8100835

Ejemplares similares